18 hours ago
9
Weighing the risks and benefits of GLP-1 drugs for kids struggling with obesity - CBS News
Watch CBS News
Childhood and teen obesity rates person soared to grounds highs with astir 1 successful 5 surviving with obesity. The FDA has approved GLP-1 drugs for value nonaccomplishment among kids 12 and older. Dr. Rachel Pessah-Pollack explains the risks and benefits, who whitethorn beryllium a campaigner and more.
English (US) ·